Viia Valge-Archer
AstraZeneca (Singapore)(SG)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction, interferon and immune responses, PARP inhibition in cancer therapy, Immune cells in cancer
Most-Cited Works
- → Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability(2016)1,052 cited
- → Nuclear factor of activated T cells contains Fos and Jun(1992)503 cited
- → The tumor microenvironment and Immunoscore are critical determinants of dissemination to distant metastasis(2016)471 cited
- → Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery(2016)412 cited
- → Development trends for monoclonal antibody cancer therapeutics(2007)387 cited
- → The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients(2018)281 cited
- → Program Death-1 Engagement Upon TCR Activation Has Distinct Effects on Costimulation and Cytokine-Driven Proliferation: Attenuation of ICOS, IL-4, and IL-21, But Not CD28, IL-7, and IL-15 Responses(2003)277 cited
- → Comprehensive Intrametastatic Immune Quantification and Major Impact of Immunoscore on Survival(2017)249 cited
- → Functional Network Pipeline Reveals Genetic Determinants Associated with in Situ Lymphocyte Proliferation and Survival of Cancer Patients(2014)225 cited
- → The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells.(1994)215 cited